From Wikipedia, the free encyclopediaJump to navigation Jump to search
|Chemical and physical data|
|Molar mass||228.29 g/mol g·mol−1|
|3D model (JSmol)|
PHA-57378 is a drug which acts as an agonist at serotonin 5-HT2 receptors, having a binding affinity of 4.1 nM at the 5-HT2A subtype and 4.3 nM at 5-HT2C. It has anxiolytic effects in animal studies.
- WO application 2000064899, Hester JB, Rogers BN, Jacobsen EJ, Ennis MD, Acker BA, Van der Velde SL, Frank KE, "Tetracyclic Azepinoindole Compounds as 5-HT Receptor Ligands", published 2 November 2000, assigned to Pharmacia Upjohn Company
- Ennis MD, Hoffman RL, Ghazal NB, Olson RM, Knauer CS, Chio CL, et al. (July 2003). "2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists". Bioorganic & Medicinal Chemistry Letters. 13 (14): 2369–72. doi:10.1016/S0960-894X(03)00403-7. PMID 12824036.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|
Retrieved from "https://en.wikipedia.org/w/index.php?title=PHA-57378&oldid=935393414"